XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.2
Segment information
 6 Months Ended
Jun. 29, 2025
Segment Reporting [Abstract]  
Segment information Segment information
An operating segment is a component (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the chief operating decision maker (in our case, our President and Chief Executive Officer) to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. The chief operating decision maker utilizes segment operating profit to evaluate operating expenses through a comparison of budget to actual results as well as an analysis of operating expenses as a percentage of revenue. We do not evaluate our operating segments using discrete asset information.
We have three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Our reportable segments primarily design, manufacture and distribute medical devices primarily used in critical care and surgical applications and generally serve two end-markets: hospitals and healthcare providers, and home health. The products of these segments are most widely used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications. The Americas also includes our OEM product portfolio that designs, manufactures and supplies devices and instruments for other medical device manufacturers.
The following tables present our segment results for the three and six months ended June 29, 2025 and June 30, 2024:
 Three Months Ended June 29, 2025
 AmericasEMEAAsiaSegment Total
Net revenues$525,637 $166,227 $89,025 $780,889 
Cost of goods sold
212,076 73,645 36,782 322,503 
Research and development expenses21,498 9,579 4,965 36,042 
Selling, general and administrative expenses124,120 42,170 25,229 191,519 
Segment operating profit (1)
$167,943 $40,833 $22,049 $230,825 
 Three Months Ended June 30, 2024
 AmericasEMEAAsiaSegment Total
Net revenues$515,632 $147,064 $86,995 $749,691 
Cost of goods sold
208,579 73,205 31,308 313,092 
Research and development expenses23,200 10,627 4,668 38,495 
Selling, general and administrative expenses121,933 39,444 25,242 186,619 
Segment operating profit (1)
$161,920 $23,788 $25,777 $211,485 
Six Months Ended June 29, 2025
AmericasEMEAAsiaSegment Total
Net revenues$1,001,361 $317,386 $162,811 $1,481,558 
Cost of goods sold
402,507 143,298 64,475 610,280 
Research and development expenses42,438 18,134 9,331 69,903 
Selling, general and administrative expenses230,688 81,848 48,014 360,550 
Segment operating profit (1)
$325,728 $74,106 $40,991 $440,825 
Six Months Ended June 30, 2024
AmericasEMEAAsiaSegment Total
Net revenues$1,009,615 $306,720 $171,205 $1,487,540 
Cost of goods sold
409,317 147,819 61,423 618,559 
Research and development expenses44,178 21,636 9,129 74,943 
Selling, general and administrative expenses233,516 77,826 48,791 360,133 
Segment operating profit (1)
$322,604 $59,439 $51,862 $433,905 
(1)Segment operating profit represents income from continuing operations before interest, loss on extinguishment of debt and taxes adjusted to exclude unallocated corporate expenses, manufacturing variances other than fixed manufacturing cost absorption variances, restructuring and impairment charges. See reconciliation of segment operating profit measures for further details.

Three Months EndedSix Months Ended
June 29, 2025June 30, 2024June 29, 2025June 30, 2024
Reconciliation of segment operating profit measure
Segment operating profit$230,825 $211,485 $440,825 $433,905 
Other unallocated expenses (1)
53,342 86,752 133,017 173,167 
Restructuring charges, separation costs and impairment charges
22,172 7,855 26,927 10,514 
Pension settlement charge— — — 138,139 
Income (loss) from continuing operations before interest and taxes
$155,311 $116,878 $280,881 $112,085 
(1) Other unallocated expenses include expenses within costs of goods sold, research and development and selling, general and administrative costs and primarily consist of manufacturing variances other than fixed manufacturing cost absorption variances and unallocated corporate function expenses.
 Three Months EndedSix Months Ended
Depreciation and amortization
June 29, 2025June 30, 2024June 29, 2025June 30, 2024
Americas$44,635 $48,538 $91,296 $95,693 
EMEA12,654 11,975 24,831 23,495 
Asia3,737 2,942 7,545 5,624 
Corporate (1)
4,686 4,674 9,371 9,361 
Consolidated depreciation and amortization$65,712 $68,129 $133,043 $134,173 
(1)Reflects depreciation and amortization included within other allocated expenses per reconciliation of segment operating profit measure.